AzTrials
AzTrials

Infant Nutrition DisordersNCT07718516

Feasibility and Validation of a Smart Changing Pad for Home Infant Weight Monitoring After Hospital Discharge

A study testing Woddle Smart Changing Pad in people with Infant Nutrition Disorders and Weight Loss, run by Stan Kachnowski at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot study evaluates the feasibility, usability, and clinical utility of the Woddle Smart Changing Pad and companion mobile application for infant monitoring following hospital or NICU discharge. Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Woddle Smart Changing Pad
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
3 sitesUnited States
Study dates
16 Dec 2025to 13 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Born at gestational age 23-0 to 42-0 weeks
  • Discharged from NICU or couplet/newborn care within 45 days prior to planned enrollment
  • Clinical indication for post-discharge growth or feeding follow-up, or documentation of a qualifying ICD-10/P-code (perinatal/growth-related, feeding/nutrition, growth/weight monitoring, or follow-up/well-newborn codes)
  • Twins/triplets permitted (one device shared per family)
  • Age ≥ 18 years
  • Primary language English, Spanish, or Chinese
  • Access to a smartphone compatible with the study app and home Wi-Fi/data plan
  • Willing and able to complete study tasks over 12 weeks of home monitoring

Who cannot join

  • Rehospitalized within 7 days prior to planned enrollment
  • Conditions making participation inappropriate or unsafe in the opinion of the treating clinician or investigator
  • Enrolled in another interventional study that conflicts with device monitoring or study endpoints
  • Declines or is unable to provide informed consent
  • Unable or unwilling to operate the device/app after training and reasonable technical support
  • Unwilling to allow collection of study data or provider/staff access to relevant clinical event data

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • HITLAB, 175 Varick St 4th floor New York

    New York, New York, 10014

  • Pediatrics 2000 III Pllc, 505 West 168th St Fl.1 NY

    New York, New York, 10032

  • Vermenton Pediatrics, 1055 E Tremont Ave, Bronx

    The Bronx, New York, 10460

Other trials in United States

About this study

Official title: Feasibility, Usability, and Validation of the Woddle Smart Changing Pad for Infant Monitoring Post-Hospital Discharge: A Pilot Study

This pilot study evaluates the feasibility, usability, and clinical utility of the Woddle Smart Changing Pad and companion mobile application for infant monitoring following hospital or NICU discharge. The study also compares infant weight measurements obtained using the Woddle scale with those from standard clinical reference scales to assess accuracy and reliability.

Read the detailed description

Infants discharged from the hospital or NICU, particularly those born preterm or with low birth weight, are at increased risk for feeding difficulties, growth faltering, dehydration, and unplanned readmission. Standard follow-up care relies on scheduled in-office weight checks and caregiver self-report, which may not capture early warning signs. The Woddle Smart Changing Pad integrates a precision weight scale with diaper event, feeding, and sleep tracking into a single connected platform; a paired mobile application allows caregivers to record and view infant health data, and a provider dashboard allows clinicians to remotely monitor trends. In this single-arm, 12-week pilot, caregiver-infant dyads used the device at home while participating providers monitored data via the dashboard. The study assessed caregiver adherence, caregiver and provider usability, agreement between device and clinic reference weights, and descriptive secondary outcomes including weight trajectory, healthcare utilization, and caregiver- and provider-reported experience.

Being tested
Woddle Smart Changing Pad
Keywords
digital health, remote patient monitoring, smart scale, neonatal weight monitoring, post discharge care, connected device
Medical subject headings
Infant Nutrition Disorders, Weight Loss, Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Woddle Smart Changing PadDevice

    Also called Woddle Baby smart changing pad and app

    A sensor-enabled infant changing pad with an integrated precision weight scale, capturing diaper events, feeding sessions, and sleep duration through caregiver input and sensors. Data sync to a companion mobile application and a secure, HIPAA-compliant provider dashboard.

Study groups in NCT07718516
Study groupRoleWhat they receive
Woddle Device GroupExperimentalAll enrolled caregiver-infant dyads received the Woddle Smart Changing Pad and companion mobile application for home use over a 12-week period, with data reviewed by participating providers via a secure dashboard.
Receives: Device: Woddle Smart Changing Pad

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Caregiver adherence

    Proportion of study days (of 84) with valid device use.

    Measured: 12 weeks.

  2. Agreement between device and clinic reference weight

    Mean bias, Bland-Altman limits of agreement, and intraclass correlation coefficient (ICC) between paired device and clinic scale weights.

    Measured: Baseline, Week 6, and Week 12.

  3. Data sync success rate

    Proportion of expected device-to-dashboard data syncs successfully received

    Measured: 12 weeks.

  4. Caregiver System Usability Scale (SUS) score

    10-item, 5-point Likert usability scale (range 0-100).

    Measured: Week 6 and Week 12.

Secondary outcomes (6)
  1. Infant weight gain trajectory

    Weekly weight gain (g/day) over the study period.

    Measured: 12 weeks

  2. Nadir weight

    Percent weight loss from birthweight; proportion of infants with ≥10% loss

    Measured: 12 weeks

  3. Healthcare utilization

    Counts of unplanned clinic visits, emergency department visits, rehospitalizations, and provider calls.

    Measured: 12 weeks.

  4. Caregiver confidence and stress

    Parenting Sense of Competence Scale (PSOC) and 0-10 confidence/stress scales.

    Measured: Baseline vs. Week 12.

  5. Provider usability and satisfaction

    Provider SUS and dashboard survey (Technology Acceptance Model - perceived usefulness, ease of use, behavioral intention).

    Measured: Week 12.

  6. Provider actions triggered by remote data

    Number and type of clinical actions (e.g., check-in calls, feeding adjustments) informed by dashboard review.

    Measured: 12 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jul 2026
  2. Study start16 Dec 2025
  3. Primary completion6 Jul 2026
  4. Study completion13 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07718516
Sponsor's protocol ID
WB-02
Status last verified
Jul 2026
First submitted
14 Jul 2026
Last updated
22 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No: Individual participant data will not be shared beyond the study team due to the small pilot sample size (N≈10 caregiver-infant dyads), which creates a meaningful risk of participant re-identification even after de-identification, given the combination of detailed clinical, demographic, and continuous home-monitoring data collected. Additionally, the informed consent obtained from participating caregivers did not include provisions for depositing or sharing individual-level data with external researchers. De-identified, aggregate findings will be made available through peer-reviewed publication and supplemental materials.

Questions about this trial

What is this clinical trial studying?

A study testing Woddle Smart Changing Pad in people with Infant Nutrition Disorders and Weight Loss, run by Stan Kachnowski at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Caregiver adherence (time frame: 12 weeks.). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in